Abstract
BackgroundAs stated in the 2013 update of RA recommendations, glucocorticoids (GCs) should be used as bridging therapy for up to 6 months, ideally tapering them at earlier time points.1ObjectivesTo evaluate...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
